15 Mid Cap Stocks Hit 52-Week Highs On Thursday
A new high list shows a clear industry pattern, raising questions about the price of strength.
Tenet Healthcare (THC) has gained 39.5% over the last month on its way to a 52-week high. As of Thursday, 15 Mid Cap US and Canada-listed stocks with a market value above $10 billion are at their strongest price of the past year. The list shows a heavy concentration in one area, with Health Care accounting for 9 of the 15 names.
This raises a critical question: are these valuations earned by the underlying business performance? The 10 largest of these names follow.
The 10 Largest, By Market Cap
- The 52-Week-High List: 20 S&P 500 Names On Friday
- S&P 500 Stocks At 52-Week Lows: Friday’s Full List
- 41 Small Cap Stocks Just Made New 52-Week Highs
- Where The Selling Ran Deepest: 12 Stocks At 52-Week Lows
- The 52-Week-High List: 19 Mid Cap Names On Friday
- S&P 500 Movers | Winners: HOOD, MRNA, COIN | Losers: MRVL, SRE, EIX
The table below shows the 10 largest of the 15 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| ILMN | $32.63 Bil | 4.0% | 10.7% | 11.7% | 109.9% |
| LH | $27.39 Bil | 0.7% | 3.2% | 18.2% | 22.0% |
| THC | $23.66 Bil | 1.5% | 2.1% | 39.5% | 53.1% |
| PR | $19.39 Bil | 3.7% | 13.1% | 11.5% | 90.0% |
| OVV | $18.68 Bil | 1.7% | 7.0% | 10.2% | 77.6% |
| NDSN | $18.68 Bil | 8.0% | 8.0% | 14.8% | 55.9% |
| APA | $15.71 Bil | 2.2% | 11.0% | 22.7% | 127.0% |
| SOLV | $15.44 Bil | 0.9% | 2.5% | 14.1% | 22.6% |
| CRL | $14.27 Bil | 0.5% | 3.6% | 33.3% | 83.9% |
| RVTY | $13.88 Bil | 3.9% | 5.6% | 12.3% | 36.2% |
But does the business performance justify the price?
Tenet Healthcare (THC) presents a strong case. Its run to a new high comes as the company grew revenue 9.4% over the last twelve months, generating an operating margin of 19.5%. The stock trades at 10.2 times trailing earnings.
Compare that to Illumina (ILMN), the largest company on the list. It trades at a much steeper 39.0 times trailing earnings, while its revenue grew 4.9% over the last twelve months. The numbers show very different profiles of growth and valuation, even at a shared 52-week high.
How should a disciplined reader treat these highs?
A 52-week-high list is a map of strength, and strong stocks often continue to perform. For context, the S&P 500 has returned +2.0% over the last month.
But a high is a price, not a verdict on a company’s quality or future. The disciplined next step is always the same: to look past the price and ask if the business fundamentals can support the new level.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
One more pattern worth noticing: 9 of the 15 names are Health Care stocks. When a whole group is making new highs together, a U.S. healthcare providers ETF like IHF is one way to own the group’s strength without betting on which single name leads it from here.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.